Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy. Benton A, Liu J, Poussin MA, Lang Goldgewicht A, et al. Cancer Cell 2025;43:1365-1376.

Read + Share

Amedeo Smart

Independent Medical Education

Benton A, Liu J, Poussin MA, Lang Goldgewicht A, et al. Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy. Cancer Cell 2025;43:1365-1376.
PMID: 40480232